Cannabis Law Report

JULY 6, 2021

In 2019, Dr. Johnson received the R. In 2004 Dr. Johnson was inducted into the Texas Hall of Fame for Science, Mathematics and Technology. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Joint Blog

FEBRUARY 24, 2021

For decades cannabis researchers have been investigating the impact cannabis has on neurological diseases. Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. This trial was to take 3.5

Treatment 55

Treatment Clinical Trials Collective Patients 55

The Cannigma

JANUARY 13, 2023

Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. Cannabis users have been reporting anecdotal relief for years, but it’s only recently that research has begun to dig into the complexities of migraines and how – or why – cannabis may be able to bring relief.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 24, 2021

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JANUARY 18, 2019

14, 2019 /PRNewswire/ — The world’s top cannabis industry leaders will convene in an unprecedented gathering in Davos, Switzerland from January 22-25. Cannabis is part and parcel of the next wave of globalization and a serious discussion in Davos could not be more timely,” said iCAN’s Saul Kaye.

Research and Development 40

Research and Development Clinical Trials Extraction Therapy 40